← Open Payments lookup

DEEPA ABHILASH: Open Payments

NPI 1831718972 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,272 in 53 payments from 11 companies in 2025. Trend: 2023 $1,200 · 2024 $1,204 · 2025 $1,272

Food & beverage: $1,272
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$292
E.R. Squibb & Sons, L.L.C.6$220
ABBVIE INC.14$208
Axsome Therapeutics, Inc.4$101
Alkermes, Inc.4$92
Lundbeck LLC4$89
Neurocrine BioSciences, Inc.3$81
Vanda Pharmaceuticals Inc.3$68
Janssen Pharmaceuticals, Inc3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44

Products named: COBENFY, VRAYLAR, REXULTI, ABILIFY MAINTENA, Auvelity, ARISTADA, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.